 |
BioCryst Pharmaceuticals BCRX (news,
chart,
quote) - BCRX option implied volatility at 81 prior to Roche collaboration
BCRX is up 1.79 to 13.60 in pre-opening trading. BCRX and Roche announced they will collaborate on clinical compound BCX-4208, for the prevention of acute rejection in transplantation and the treatment of autoimmune diseases. BCRX December option implied volatility of 81 is near its 6-week average. Average option implied volatility indicated average standard deviation stock price movements
|
|
|
|
